quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:05·158d
SECFiling
Verona Pharma plc logo

SEC Form EFFECT filed by Verona Pharma plc

VRNA· Verona Pharma plc
Health Care
Original source

Companies

  • VRNA
    Verona Pharma plc
    Health Care

Recent analyst ratings

  • Jul 14UpdateH.C. Wainwright-
  • Jul 1UpdateWolfe Research$170.00
  • Apr 28UpdateTD Cowen$100.00
  • Apr 21UpdateCantor Fitzgerald$80.00
  • Jan 10UpdateROTH MKM$68.00
  • Oct 3UpdateWells Fargo$50.00

Related

  • SEC160d
    SEC Form SCHEDULE 13G filed by Verona Pharma plc
  • SEC160d
    Amendment: SEC Form SCHEDULE 13G/A filed by Verona Pharma plc
  • SEC160d
    Amendment: SEC Form SCHEDULE 13G/A filed by Verona Pharma plc
  • SEC188d
    SEC Form 15-12G filed by Verona Pharma plc
  • INSIDER197d
    General Counsel Fisher Andrew returned 1,349,887 units of Ordinary Shares to the company and converted options into 931,984 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER197d
    President and CEO Zaccardelli David returned 15,461,424 units of Ordinary Shares to the company and converted options into 3,285,280 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER197d
    Chief Medical Officer Rickard Kathleen A. returned 3,564,852 units of Ordinary Shares to the company and converted options into 1,131,984 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER197d
    Chief Financial Officer Hahn Mark W returned 14,550,248 units of Ordinary Shares to the company and converted options into 3,285,280 units of Ordinary Shares, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022